Randox Lipoprotein (a) Diagnostic Assay Lacks FDA Clearance, Recalled
Randox Laboratories is recalling 33 Randox Lipoprotein (a) diagnostic kits nationwide. The assay's claims for use on Roche Cobas c501 analyzers lack required FDA clearance or approval.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for diagnostic assay with unvalidated claims that lack required regulatory clearance. No illnesses or injuries have been reported. Per the severity rubric, a risk-of-harm product without reported injury is classified as High (score 3).
Plain-English summary
Randox Laboratories, Limited is recalling 33 kits of the Randox Lipoprotein (a) diagnostic assay, Catalog Number LP2757 (UDI-DI: 05055273209198). This in vitro diagnostic (IVD) kit is used on automated laboratory analyzers.
The recall was initiated because the assay's claims for use on Roche Cobas c501 analyzers with nmol/l measurement units lack the required FDA clearance (510(k)) or approval (PMA).
The recall affects all lots that are still within their expiration date. Distribution includes nationwide coverage in the United States and Puerto Rico.
The recalled product
- Product
- Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP2757
- Manufacturer
- Randox Laboratories, Limited
- Affected units
- 33
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UDI-DI: 05055273209198 All lots within expiry
Distribution
Part of a larger recall action
This product is one of 2 recalled by Randox Laboratories, Limited under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Randox Laboratories, Limited
See all →- HighRandox Lipoprotein (a) assay distributed without required FDA clearance
FDA (Devices) · 2025-01-29
- ModerateRandox RX Daytona Plus Clinical Chemistry Analyzer Software Recall
FDA (Devices) · 2020-03-04
- ModerateRandox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
FDA (Devices) · 2019-11-27
- ModerateRandox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
FDA (Devices) · 2019-11-27
- ModerateRandox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
FDA (Devices) · 2019-11-27